USA Financial Formulas’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

USA Financial Formulas’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,500	Closed	-$110K	–	451
2020 Q4	$110K	Buy	+1,500	New	+$111K	0.09%	145
2020 Q2	–	Sell	-22,314	Closed	-$661K	–	350
2020 Q1	$661K	Buy	+22,314	New	+$755K	0.42%	70
2019 Q3	–	Sell	-15,202	Closed	-$402K	–	278
2019 Q2	$402K	Buy	15,202 +1,792	+13%	+$45.5K	0.2%	60
2019 Q1	$354K	Buy	+13,410	New	+$318K	0.22%	59

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

USA Financial Formulas's HZNP Position: Q1 2021 in Review

USA Financial Formulas sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2021, closing a stake of 1,500 shares — an estimated $110K sold.

USA Financial Formulas first reported a position in HZNP in Q1 2019 and held it in 4 quarters. The position peaked at $661K in Q1 2020. 516 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.

USA Financial Formulas reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2021 after selling out during the quarter.
USA Financial Formulas sold 1,500 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $110K.
USA Financial Formulas first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 4 quarters.
USA Financial Formulas's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $661K in Q1 2020.
516 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.

Based on USA Financial Formulas's 13F filing for Q1 2021, filed 6 May 2021.